Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Triamcinolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pain 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Keratosis, Actinic 1 Hodgkin Disease 1 Dermatitis, Contact 1 Dendritic Cell Sarcoma, Interdigitating 1 Chalazion 1 Carcinoma, Basal Cell 1 Burkitt Lymphoma 1 Anemia, Refractory, with Excess of Blasts 1 Adenomyosis 1

Interventions

Fentanyl 24 Analgesia 19 Acupuncture Therapy 17 Morphine 16 Surveys and Questionnaires 15 Zoledronic Acid 13 Oxycodone 13 Therapeutics 12 Acetaminophen 12 Radiotherapy 11 Lidocaine 11 Ketamine 11 Hydromorphone 11 Psychiatric Rehabilitation 10 Methadone 10 Ibandronic Acid 10 Bupivacaine 9 Ropivacaine 8 nabiximols 7 Analgesics, Opioid 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Yoga 4 Therapeutic Touch 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡